ANGO News and Press, AngioDynamics Inc. From 09/09/25

2025-09-09 16:15:00 ET The medical device market offers investors unique exposure to the overall life science space, especially in an era of fast-growing tech advancements in healthcare. This industry covers a wide range of health and medical instruments and equipment used in the tr...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that Jim Clemmer, President and...

Trial Investigates Use of Auryon Atherectomy System in Cases with Challenging Below-the-Knee Blockages AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving...

Peer-reviewed findings demonstrate high disease control and quality-of-life preservation, supporting shift toward focal therapy in prostate treatment AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in ...

2025-07-15 16:42:14 ET Tuesday started off well for AngioDynamics (NASDAQ: ANGO) , maker of such medical devices as the NanoKnife tool for "electrocuting" cancer, as well as multiple devices for treating peripheral vascular disease. In the morning, AngioDynamics reported stronge...

2025-07-15 12:42:07 ET More on AngioDynamics AngioDynamics, Inc. (ANGO) Q4 2025 Earnings Call Transcript AngioDynamics, Inc. 2025 Q4 - Results - Earnings Call Presentation AngioDynamics Non-GAAP EPS of -$0.03 beats by $0.09, revenue of $80.16M beats by $5.9M ...

2025-07-15 12:40:56 ET AngioDynamics, Inc. (ANGO) Q4 2025 Earnings Conference Call July 15 2025, 08:00 AM ET Company Participants James C. Clemmer - CEO, President & Director Stephen A. Trowbridge - Executive VP & CFO Conference Call Participants ...

America Movil S.A.B. de C.V.n Depositary Shares (each representing the right to receive twenty (20) Series B Shares (AMX) is expected to report $0.49 for Q2 2025 Albertsons Companies Inc. Class A (ACI) is expected to report $0.49 for Q1 2026 AmeriServ Financial Inc. (ASRV) is expected to ...

2025-07-15 06:32:25 ET More on AngioDynamics Seeking Alpha’s Quant Rating on AngioDynamics Historical earnings data for AngioDynamics Financial information for AngioDynamics Read the full article on Seeking Alpha For further details see: An...

Med Tech franchise delivers third consecutive quarter of over 20% revenue growth Reported strong adjusted EBITDA in the fourth quarter resulting in positive adjusted EBITDA for full fiscal year 2025 Drove $16.2 million of free cash flow in the quarter as a result of strong...